Brief: FDA Says Getinge & Maquet Cardiovascular Update Use Instructions For Vasoview HemoPro 2 (Vh-4000 And Vh-4001) EVH Systems
Jan 15 (Reuters) - FDA:
* FDA: GETINGE AND MAQUET CARDIOVASCULAR UPDATE USE
INSTRUCTIONS
FOR VASOVIEW HEMOPRO 2 (VH-4000 AND VH-4001) EVH SYSTEMS -
WEBSITE
* FDA: 7 REPORTED SERIOUS INJURIES RELATED TO GETINGE &
MAQUET
CARDIOVASCULAR VASOVIEW HEMOPRO 2 (VH-4000 AND VH-4001) EVH
SYSTEMS
* FDA: USE INSTRUCTIONS UPDATE FOR SOME GETINGE VASOVIEW
HEMOPRO 2
EVH SYSTEMS DUE TO POSSIBILITY OF TWO FAILURE MODES EXPERIENCED
DURING USE
Further company coverage: GETIb.ST
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment